Literature DB >> 24934446

Prostate cancer: viral gene therapy can improve IMRT.

David Killock.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24934446     DOI： 10.1038/nrurol.2014.138

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer.

Authors:  Svend O Freytag; Hans Stricker; Mei Lu; Mohamed Elshaikh; Ibrahim Aref; Deepak Pradhan; Kenneth Levin; Jae Ho Kim; James Peabody; Farzan Siddiqui; Kenneth Barton; Jan Pegg; Yingshu Zhang; Jingfang Cheng; Nancy Oja-Tebbe; Renee Bourgeois; Nilesh Gupta; Zhaoli Lane; Ron Rodriguez; Theodore DeWeese; Benjamin Movsas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-05       Impact factor: 7.038
  1 in total
  1 in total

1.  Radiosensitizing effects of Sestrin2 in PC3 prostate cancer cells.

Authors:  Hao Fu; Wenke Song; Yufei Wang; Wenyi Deng; Tingting Tang; Wenjing Fan; Shunlin Qu
Journal:  Iran J Basic Med Sci       Date:  2018-06       Impact factor: 2.699
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.